Companion apps for patients and their treatment challenges

We partner with pharma to help patients manage both their medications and mental health challenges. A comprehensive approach for improved outcomes.

Book demo

Highlight

How Vicore Pharma and Alex Therapeutics partnered to build Almee™ - a digital therapy to treat anxiety for patients with pulmonary fibrosis

Learn more

Highlight

Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety

Learn more

A trusted digital health partner to pharma

Specialized support for cancer and rare disease management

We specialize in creating evidence-based tools for people with cancer and rare diseases, where complex treatment regimes and high mental health comorbidity can make it particularly difficult to stay on top of treatment plans.

Empowering patients to manage their treatment effectively.

Go beyond simple medication reminders and discover how symptoms and medications are related, using our AI-integrated therapy companion - fully customisable to support any patient population or treatment.

Therapy Companions

Deliver engaging digital therapies that are evidence-based and clinically proven.

We're a pioneer in building Software as a Medical Device (SaMD) products that have been proven to provide clinically and statistically significant benefit to patients, across a range of indications.

Pharma Partners

News & Insights

Who’s Caring for Caregivers? The Emotional Toll in the Rare Disease Community

November 20, 2024

The Impact of Mental Health in Rare Disease

October 3, 2024

Alex Therapeutics has signed an exclusive agreement with Navamedic for development of a Companion App to aid in the treatment of Parkinson’s Disease

September 12, 2024

More Insights

Improve patient outcomes with digital companions proven to change behavior.

We've simplified the process for pharma companies to launch indication-specific companion digital health solutions at scale. Reach out to learn more.

Get in touch